Capecitabine lipid nanoparticles for anti-colon cancer activity in 1, 2-dimethylhydrazine induced colon cancer: Preparation, cytotoxic, pharmacokinetic and pathological evaluation

Narendar Dudhipala, Goverdhan Puchchakayala
  • Drug Development and Industrial Pharmacy, March 2018, Taylor & Francis
  • DOI: 10.1080/03639045.2018.1445264

Capecitabine solid lipid nanoparticles for anti-colon cancer activity

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/03639045.2018.1445264

The following have contributed to this page: Narendar Dudhipala

In partnership with: